
USD
$0.00
(0.00%
)At Close (As of Dec 17, 2025)
$25.78B
Market Cap
36.53
P/E Ratio
1.8
EPS
$93.25
52 Week High
$54.11
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.4B |
| Total Revenue | $4B |
| Cost Of Revenue | $1.6B |
| Costof Goods And Services Sold | $1.6B |
| Operating Income | $600M |
| Selling General And Administrative | $1.1B |
| Research And Development | $552M |
| Operating Expenses | $1.8B |
| Investment Income Net | - |
| Net Interest Income | $115M |
| Interest Income | $134M |
| Interest Expense | $19M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $218M |
| Income Before Tax | $709M |
| Income Tax Expense | $133M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $576M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $728M |
| Ebitda | $946M |
| Net Income | $576M |
| Field | Value (USD) |
|---|---|
| Total Assets | $6.5B |
| Total Current Assets | $4.3B |
| Cash And Cash Equivalents At Carrying Value | $606M |
| Cash And Short Term Investments | $606M |
| Inventory | $543M |
| Current Net Receivables | $1B |
| Total Non Current Assets | $2.2B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $103M |
| Intangible Assets Excluding Goodwill | $103M |
| Goodwill | $23M |
| Investments | - |
| Long Term Investments | $119M |
| Short Term Investments | $2B |
| Other Current Assets | $146M |
| Other Non Current Assets | - |
| Total Liabilities | $4.4B |
| Total Current Liabilities | $2.9B |
| Current Accounts Payable | $345M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.2B |
| Total Non Current Liabilities | $1.4B |
| Capital Lease Obligations | $146M |
| Long Term Debt | $1.2B |
| Current Long Term Debt | $1.2B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $2.6B |
| Other Current Liabilities | $1.3B |
| Other Non Current Liabilities | $18M |
| Total Shareholder Equity | $2.1B |
| Treasury Stock | - |
| Retained Earnings | $1.6B |
| Common Stock | $400K |
| Common Stock Shares Outstanding | $413M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.4B |
| Total Revenue | $4B |
| Cost Of Revenue | $1.6B |
| Costof Goods And Services Sold | $1.6B |
| Operating Income | $600M |
| Selling General And Administrative | $1.1B |
| Research And Development | $552M |
| Operating Expenses | $1.8B |
| Investment Income Net | - |
| Net Interest Income | $115M |
| Interest Income | $134M |
| Interest Expense | $19M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $218M |
| Income Before Tax | $709M |
| Income Tax Expense | $133M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $576M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $728M |
| Ebitda | $946M |
| Net Income | $576M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
DexCom, Inc. is a leading innovator in diabetes management, best known for its advanced continuous glucose monitoring (CGM) systems that enable patients to maintain optimal glucose levels. Headquartered in San Diego, California, with a manufacturing facility in Mesa, Arizona, DexCom is committed to enhancing the quality of life for individuals with diabetes through cutting-edge technology and superior product offerings. The company is expanding its global footprint to address the increasing demand for reliable diabetes management solutions, solidifying its role as a pivotal player in the healthcare sector.